HighTower Advisors LLC Has $399,000 Position in Inspire Medical Systems, Inc. (NYSE:INSP)

HighTower Advisors LLC lifted its holdings in Inspire Medical Systems, Inc. (NYSE:INSP) by 46.9% in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 2,150 shares of the company’s stock after buying an additional 686 shares during the period. HighTower Advisors LLC’s holdings in Inspire Medical Systems were worth $399,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also modified their holdings of INSP. Smartleaf Asset Management LLC boosted its stake in shares of Inspire Medical Systems by 178.9% during the 4th quarter. Smartleaf Asset Management LLC now owns 357 shares of the company’s stock valued at $66,000 after buying an additional 229 shares during the period. Merit Financial Group LLC purchased a new stake in shares of Inspire Medical Systems during the fourth quarter worth $313,000. Public Employees Retirement System of Ohio boosted its position in Inspire Medical Systems by 9.4% during the third quarter. Public Employees Retirement System of Ohio now owns 36,361 shares of the company’s stock valued at $7,674,000 after purchasing an additional 3,125 shares during the last quarter. Jennison Associates LLC purchased a new position in Inspire Medical Systems in the fourth quarter valued at about $8,821,000. Finally, Janney Montgomery Scott LLC increased its position in Inspire Medical Systems by 248.5% in the 4th quarter. Janney Montgomery Scott LLC now owns 4,806 shares of the company’s stock worth $891,000 after purchasing an additional 3,427 shares during the last quarter. Hedge funds and other institutional investors own 94.91% of the company’s stock.

Inspire Medical Systems Stock Performance

Shares of INSP stock opened at $159.60 on Tuesday. The firm has a fifty day moving average of $178.78 and a 200-day moving average of $189.61. The stock has a market cap of $4.75 billion, a price-to-earnings ratio of 92.26, a P/E/G ratio of 2.86 and a beta of 1.48. Inspire Medical Systems, Inc. has a 52-week low of $123.00 and a 52-week high of $257.40.

Inspire Medical Systems (NYSE:INSP) last posted its earnings results on Monday, February 10th. The company reported $1.15 earnings per share for the quarter, beating analysts’ consensus estimates of $0.74 by $0.41. Inspire Medical Systems had a net margin of 6.67% and a return on equity of 8.19%. On average, sell-side analysts predict that Inspire Medical Systems, Inc. will post 2.16 earnings per share for the current year.

Analyst Ratings Changes

INSP has been the topic of several recent research reports. KeyCorp reaffirmed an “overweight” rating and set a $234.00 price objective (down previously from $236.00) on shares of Inspire Medical Systems in a research report on Friday, January 24th. Wells Fargo & Company reduced their price objective on shares of Inspire Medical Systems from $198.00 to $195.00 and set an “equal weight” rating for the company in a research note on Tuesday, February 11th. Royal Bank of Canada reiterated an “outperform” rating and issued a $260.00 price objective on shares of Inspire Medical Systems in a report on Tuesday, February 11th. Piper Sandler cut their target price on Inspire Medical Systems from $260.00 to $233.00 and set an “overweight” rating on the stock in a report on Monday, February 10th. Finally, Morgan Stanley decreased their price target on Inspire Medical Systems from $230.00 to $220.00 and set an “overweight” rating for the company in a research note on Tuesday, February 11th. Three research analysts have rated the stock with a hold rating and seven have given a buy rating to the company. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $226.70.

Insider Buying and Selling

In other Inspire Medical Systems news, insider Randy Ban sold 25,584 shares of the business’s stock in a transaction dated Thursday, February 13th. The shares were sold at an average price of $183.50, for a total value of $4,694,664.00. Following the transaction, the insider now directly owns 7,259 shares in the company, valued at $1,332,026.50. The trade was a 77.90 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, CTO John Rondoni sold 583 shares of the firm’s stock in a transaction that occurred on Tuesday, February 11th. The stock was sold at an average price of $170.49, for a total transaction of $99,395.67. Following the sale, the chief technology officer now directly owns 10,424 shares of the company’s stock, valued at approximately $1,777,187.76. The trade was a 5.30 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 26,225 shares of company stock worth $4,806,530 in the last 90 days. 4.10% of the stock is owned by company insiders.

Inspire Medical Systems Profile

Inspire Medical Systems, Inc, a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA.